Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread (Q30432264)

21 June 2017

1 reference

22 October 2022

Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread (English)

1 reference

Middle East respiratory syndrome coronavirus

21 June 2017

main subject

0 references

0 references

1 reference

Middle East respiratory syndrome

1 reference

respiratory tract infection

inferred from title

1 reference

22 October 2022

Lu Lu

1

0 references

Lanying Du

series ordinal

3

object named as

Lanying Du

1 reference

21 June 2017

Qi Liu

2

1 reference

21 June 2017

Shibo Jiang

series ordinal

4

1 reference

21 June 2017

language of work or name

1 reference

19 June 2013

2 references

21 June 2017

22 October 2022

Microbes and Infection

2 references

21 June 2017

22 October 2022

15

1 reference

21 June 2017

issue

8-9

1 reference

21 June 2017

page(s)

625-629

1 reference

HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds

21 June 2017

cites work

1 reference

12 December 2020

An interferon-gamma-related cytokine storm in SARS patients

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

1 reference

12 December 2020

SARS: systematic review of treatment effects

1 reference

12 December 2020

A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC.

1 reference

12 December 2020

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

1 reference

12 December 2020

Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database.

1 reference

12 December 2020

HIV-1 inhibition by a peptide

1 reference

12 December 2020

Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus

1 reference

12 December 2020

Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012.

1 reference

12 December 2020

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

1 reference

12 December 2020

Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation

1 reference

12 December 2020

Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group

1 reference

12 December 2020

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

1 reference

12 December 2020

The spike protein of SARS-CoV--a target for vaccine and therapeutic development

1 reference

12 December 2020

A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge

1 reference

12 December 2020

Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

Preparing for the next pandemic

1 reference

12 December 2020

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

12 December 2020

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

1 reference

12 December 2020

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

1 reference

12 December 2020

Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome

1 reference

12 December 2020

SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement

1 reference

12 December 2020

Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus

1 reference

12 December 2020

Novel therapies based on mechanisms of HIV-1 cell entry.

1 reference

12 December 2020

Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants

1 reference

12 December 2020

1 reference

12 December 2020

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

1 reference

12 December 2020

Into the eye of the cytokine storm

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC.

1 reference

12 December 2020

Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV.

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

10.1016/J.MICINF.2013.06.003

Identifiers

DOI

1 reference

21 June 2017

0 references

1 reference